CISYS Advancing Lupus Research at ACR
We are excited to share that CISYS LifeSciences will be attending ACR Convergence 2024 in Washington, D.C., from November 17-19. This is a fantastic opportunity for us to connect with dedicated rheumatology researchers and healthcare professionals looking to advance their work.
We are excited to share that CISYS LifeSciences will be attending ACR Convergence 2024 in Washington, D.C., from November 17-19. This is a fantastic opportunity for us to connect with dedicated rheumatology researchers and healthcare professionals looking to advance their work.
Our suite of tools is tailored to support rheumatology research, providing streamlined solutions for patient eligibility, adjudication, and CRO-site communications. Whether you're focused on improving trial efficiency, enhancing data accuracy, or optimizing collaboration, we're here to support your research goals.
While we won't have a booth, our team will be on the floor and would love to meet with you over food or drinks to discuss how CISYS can help advance your research efforts. If you're interested, reach out to schedule a time. We look forward to connecting and exploring how we can make a meaningful impact together!
Pre-Randomization Review
Designed to meet the needs of SLE studies, which commonly require pre-randomization eligibility confirmation. Our platform enables centralized review for accuracy in identifying patients with key biomarkers and clinical symptoms.
Customizable Workflows
Tailor workflows for your study's unique lupus eligibility criteria, such as laboratory and clinical manifestations, allowing both internal and external reviewers to collaborate efficiently.
Integrated WebSXP Site Communication and Exchange Portal
Facilitate seamless communication between sites and eligibility reviewers for timely exchange of critical documents, including lab results and imaging, to confirm eligibility based on essential study-specific criteria.
Full Data Integration
Aggregate data from sites, central laboratories, imaging, and more, ensuring reviewers have comprehensive information, including biomarker profiles such as ANA and complement levels like C3 and C4 for accurate decision-making.
Why This Matters for Lupus Research
Accelerates patient identification by focusing on biomarkers and symptoms critical to SLE, such as joint inflammation, renal involvement, and antibody profiles.
Ensures consistency and reliability in adjudication for SLE-specific outcomes, supporting high data integrity and adherence to regulatory standards.
Enhances inter-site communication to streamline trials and minimize delays in data sharing between sites, CROs, and sponsors.
Advanced Adjudication and Communication Tools for Informed Decision-Making in SLE Trials
Targeted Adjudication for SLE Endpoints and Biomarkers
Customizable Concordance Workflows: Fully tailored workflows with QC steps and dossier routing enable precise assessment of complex lupus endpoints.
Intuitive Dashboards: Provide committee members with straightforward interfaces to review patient data, such as laboratory results, physical examination findings, and other supporting documentation, facilitating quick, well-informed decisions on patient eligibility.
Integrated Communication and Document Exchange
WebSXP Site Portal: Unified document exchange and secure portal to enhance communication on eligibility and adjudication tasks, including intelligent forms, ensuring accurate assessment of complex lupus symptoms and comorbidities.
Automated Reminders and Notifications: Ensure that time-sensitive tasks related to eligibility and document submission are completed promptly, minimizing delays in patient recruitment and trial progress.
Comprehensive Reporting and Data for Enhanced SLE Research
Detailed Reporting: Access comprehensive metrics on patient eligibility, disease activity adjudication, and biomarker trends, providing insights to improve patient selection and endpoint validation.
API Integration: Supports seamless data connection with external systems for rapid access to EDC data, real-time lab results, and imaging.
Committee Meeting Management Module: Schedule and organize adjudication meetings, ensuring quick turnaround on eligibility and outcome reviews.
Partner with CISYS for Precision in Lupus Clinical Trials
CISYS LifeSciences provides a specialized, fully integrated platform tailored to the challenges of SLE research. Our tools enhance patient eligibility, adjudication efficiency, and site communication for better decision-making in lupus trials. Contact us for a customized demo or pilot opportunity to see how our platform can elevate your lupus research.